Pseudoloma in zebrafish: detect infection early

A zebrafish colony can carry Pseudoloma neurophilia without dramatic mortality or an obvious external lesion. This microsporidian parasite primarily targets the nervous system and may alter body condition, reproduction or behaviour before a reliable clinical signal appears. For a research facility, the issue therefore extends beyond diagnosing overt disease: an unplanned chronic infection can affect animal welfare, line transfers and the interpretation of experimental results.

A quiet infection that can become an experimental variable

The 2024 review by Schuster and colleagues describes P. neurophilia as the infectious agent most frequently diagnosed in zebrafish facilities. Most infected fish show no specific outward signs. When weight loss, abnormal swimming or reduced reproductive performance occurs, none is sufficiently discriminating to identify this parasite without further investigation.

The organism forms clusters of spores in the brain, spinal cord and nerve roots, and muscle involvement may also occur. This distribution helps explain how an apparently stable colony can introduce non-protocol variation into behavioural, neurological, immunological or reproductive research. An experimental study involving three wild-type strains associated exposure with lower body condition in females, but not males. That finding does not predict the effect in every line; it does show why unknown health status is more than an administrative gap.

Daily observation remains essential for identifying mortality, loss of condition, reduced spawning or altered swimming. It cannot exclude a subclinical infection. Colony status needs to be supported by a documented diagnostic plan rather than by the appearance of the fish alone.

PCR and histopathology answer different questions

Schuster et al. followed experimental infection after a low-dose exposure of 8,000 spores per fish. Whole-body quantitative PCR detected parasite DNA from four days after exposure, whereas histopathology did not demonstrate infection until day 92. Through the end of follow-up at day 334, PCR generally identified more positive fish than histology.

This difference does not make PCR a universal replacement for tissue examination. A positive amplification result shows that the genetic target is present in the sample; it does not locate tissue damage or, by itself, demonstrate viable spores. Histopathology links the parasite to affected structures, describes associated lesions and can reveal processes that were not included in a targeted assay. Its sensitivity still depends on the plane of section, infection stage and distribution of parasite clusters. In the study, adding a second slide increased overall detection only from 24% to 26%, a difference that was not statistically significant.

Sampling must follow the intended decision. A whole fish provides a standardised target for a specific assay but requires lethal collection. Fish found dead may be too autolysed for useful histology. Pooling improves efficiency but may dilute a rare target and does not provide individual prevalence. Before collection, teams should define the epidemiological unit, sample numbers, controls, handling of indeterminate findings and the action attached to a positive result.

Environmental DNA adds surveillance without certifying each fish

An environmental DNA method has been evaluated using tank water. During a ten-month experimental follow-up, the parasite was detected immediately after exposure and through week four, became undetectable until week seven, and was then found intermittently. At the Zebrafish International Resource Center, the assay detected parasite DNA in water from all seven tanks confirmed positive by fish testing and did not detect it in the four negative tanks examined.

This approach is valuable for repeated surveillance without sacrificing important lines. It does not allow a negative water sample to certify every fish as free of infection. Detection probability varies with prevalence, filtered volume, resuspension of debris, the period without flow and the parasite life cycle. Under published experimental conditions, samples collected after a static period were more informative than samples taken under continuous flow. Each facility must validate its sampling method and combine water testing with direct examination when risk or the decision requires it.

Transmission requires barriers beyond disinfected embryos

P. neurophilia spreads horizontally through the environment, ingestion of spores or infected tissue, and contact between populations. Reproduction also contributes to risk. In a study of 27 infected breeding pairs, parasite DNA was detected in eggs from four spawns and in spawning water from eleven. Estimated intraovum prevalence in positive spawns was low, approximately 0.9%, but spores were directly observed inside embryos.

A low frequency still matters when one spawn produces many offspring that are then reared together. More importantly, surface disinfection cannot remove a parasite that is already within the egg. Validated embryo disinfection remains useful against external material, but it must not be presented as proof that Pseudoloma is absent.

Biosecurity should combine a useful source health report, genuinely separate quarantine, dedicated equipment, workflows from the best-known status towards the least certain, and prompt carcass removal. Spawning chambers, siphons, nets and surfaces exposed to fish or water should not move between units without a validated cleaning and disinfection procedure. A line received as embryos is still a biological introduction requiring risk assessment; it is not pathogen-free by definition.

No routine treatment has been demonstrated

One trial fed diets containing albendazole, fumagillin or both to approximately 250 previously infected adult zebrafish for four weeks. Whole-body PCR was performed at four time points through week 16. The study found no statistically significant association between treatment group and parasite prevalence. Potentially relevant reductions occurred in some groups at selected time points, but they did not demonstrate clearance or establish a transferable treatment protocol.

Facilities should therefore not improvise population medication in an attempt to “clean” a colony. Management starts with prevention, screening, separation and a documented response to detection. Depending on scientific objectives and risk, that response may include confirmation, movement restrictions, assessment of distribution, rederivation from screened broodstock or removal of affected populations.

Build a programme that protects animals and data

A facility can strengthen its approach in five steps: define excluded agents according to its research programmes; trace source and line status; combine clinical observation, targeted assays and broad tissue examination; specify decision thresholds and responsibilities before results arrive; and reassess the programme after an introduction, clinical signal or water-system change. Surveillance frequency should not be copied mechanically from another institution. It depends on system connectivity, exchange patterns, line value and the potential impact on protocols.

Vetofish can support research facilities with risk assessment, sampling design, specimen collection, selection between PCR, histopathology and environmental water testing, and joint interpretation of results. The aim is a proportionate, traceable decision that does not confuse absence of signs, one negative test and demonstrated health status.